{"id":"gentian-violet","rwe":[{"pmid":"41772988","year":"2026","title":"Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa.","finding":"","journal":"Expert review of clinical pharmacology","studyType":"Clinical Study"},{"pmid":"41764862","year":"2026","title":"Integrative Ayurveda management of a chronic unilateral diabetic plantar lesion: A case report.","finding":"","journal":"Explore (New York, N.Y.)","studyType":"Clinical Study"},{"pmid":"41725525","year":"2026","title":"An optical fiber crystal violet sensor using a porous ITO membrane coated on an optical fiber surface with UV photon-enhanced sensitivity.","finding":"","journal":"The Analyst","studyType":"Clinical Study"},{"pmid":"41642131","year":"2026","title":"Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy.","finding":"","journal":"Journal of drugs in dermatology : JDD","studyType":"Clinical Study"},{"pmid":"41510595","year":"2026","title":"Evaluating Gentian Violet as a Low-Cost Alternative for Sentinel Lymph Node Biopsy in Breast Cancer: A Single-Center Retrospective Study.","finding":"","journal":"Asia-Pacific journal of clinical oncology","studyType":"Clinical Study"}],"_fda":{"id":"25ca89ae-690a-e0dd-e063-6294a90aa3d7","set_id":"1922518d-e49b-5010-e063-6394a90a9112","openfda":{"unii":["J4Z741D6O5"],"route":["TOPICAL"],"spl_id":["25ca89ae-690a-e0dd-e063-6294a90aa3d7"],"brand_name":["Sanar Naturals Gentian Violet"],"spl_set_id":["1922518d-e49b-5010-e063-6394a90a9112"],"package_ndc":["73386-152-30"],"product_ndc":["73386-152"],"generic_name":["GENTIAN VIOLET"],"product_type":["HUMAN OTC DRUG"],"substance_name":["GENTIAN VIOLET"],"manufacturer_name":["Sanvall Enterprises, Inc"],"application_number":["M003"],"is_original_packager":[true]},"purpose":["Purpose First Aid Antiseptic"],"version":"2","stop_use":["Stop use and ask a doctor if redness, irritation, swelling, or pain persists or increases or if infection occurs."],"warnings":["Warnings For external treatment of abrasions and minor cuts Do not Do not apply to an ulcerative lesions as this may cause tattooing of the skin. Do not use in eyes Stop use and ask a doctor if redness, irritation, swelling, or pain persists or increases or if infection occurs. Keep out of reach of children. In case of ingestion, seek medical help or contact Poison Control Center immediately."],"ask_doctor":["Do not Do not apply to an ulcerative lesions as this may cause tattooing of the skin. Do not use in eyes"],"effective_time":"20241031","active_ingredient":["Active ingredient Gentian Violet 0.1% Purpose First Aid Antiseptic"],"inactive_ingredient":["Inactive ingredients Isopropyl Alcohol, Aqua"],"indications_and_usage":["Uses For external treatment of abrasions and minor cuts."],"other_safety_information":["Other Information Will stain skin or clothing"],"dosage_and_administration":["Directions Clean the affected area and apply directly to the wound or use a cotton applicator once or twice daily. Do not bandage."],"spl_product_data_elements":["Sanar Naturals Gentian Violet Gentian Violet ISOPROPYL ALCOHOL WATER GENTIAN VIOLET GENTIAN VIOLET CATION"],"keep_out_of_reach_of_children":["Keep out of reach of children. In case of ingestion, seek medical help or contact Poison Control Center immediately."],"package_label_principal_display_panel":["Label copy label"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Muscarinic acetylcholine receptor M4","category":"target"},{"label":"CHRM4","category":"gene"},{"label":"ADRA2A","category":"gene"},{"label":"CHRM1","category":"gene"},{"label":"Topical","category":"route"},{"label":"Liquid","category":"form"},{"label":"Solution","category":"form"},{"label":"Swab","category":"form"},{"label":"Tincture","category":"form"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Active","category":"status"},{"label":"Candidal vulvovaginitis","category":"indication"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Anti-Infective Agents, Local","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"11 reports"},{"date":"","signal":"CONDITION AGGRAVATED","source":"FDA FAERS","actionTaken":"7 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"7 reports"},{"date":"","signal":"THERAPEUTIC PRODUCT EFFECT INCOMPLETE","source":"FDA FAERS","actionTaken":"6 reports"},{"date":"","signal":"TREATMENT FAILURE","source":"FDA FAERS","actionTaken":"6 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"5 reports"},{"date":"","signal":"ARTHROPATHY","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"DRUG HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"DRUG RESISTANCE","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"HALLUCINATION","source":"FDA FAERS","actionTaken":"4 reports"}],"contraindications":["Aphthous ulcer of mouth","Vaginal irritation"]},"trials":[],"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-03-20","unitCost":"$0.0512/ML","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$18","description":"GENTIAN VIOLET 1% SOLUTION","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GENTIAN VIOLET","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:23:09.581757+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:23:15.222409+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GENTIAN VIOLET","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:23:15.494035+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:23:08.311925+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:23:08.311950+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:23:16.972689+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: DNA inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:23:16.544902+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL64894/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:23:16.200984+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M003","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:23:08.311954+00:00"}},"allNames":"methylrosaniline chloride","offLabel":[],"synonyms":["methylrosaniline chloride","gentian violet"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Methylrosaniline Chloride","ecosystem":[{"indication":"Candidal vulvovaginitis","otherDrugs":[{"name":"butoconazole","slug":"butoconazole","company":"Bayer"},{"name":"clotrimazole","slug":"clotrimazole","company":""},{"name":"fluconazole","slug":"fluconazole","company":"Pfizer"},{"name":"miconazole","slug":"miconazole","company":"Insight Pharms"}],"globalPrevalence":null}],"mechanism":{"target":"Muscarinic acetylcholine receptor M4","novelty":"First-in-class","targets":[{"gene":"CHRM4","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M4","protein":"Muscarinic acetylcholine receptor M4"},{"gene":"ADRA2A","source":"DrugCentral","target":"Alpha-2A adrenergic receptor","protein":"Alpha-2A adrenergic receptor"},{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M1","protein":"Muscarinic acetylcholine receptor M1"},{"gene":"ADRA2C","source":"DrugCentral","target":"Alpha-2C adrenergic receptor","protein":"Alpha-2C adrenergic receptor"},{"gene":"DRD3","source":"DrugCentral","target":"D(3) dopamine receptor","protein":"D(3) dopamine receptor"},{"gene":"CHRM5","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M5","protein":"Muscarinic acetylcholine receptor M5"},{"gene":"EGFR","source":"DrugCentral","target":"Epidermal growth factor receptor","protein":"Epidermal growth factor receptor"},{"gene":"CHRM2","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M2","protein":"Muscarinic acetylcholine receptor M2"},{"gene":"TACR2","source":"DrugCentral","target":"Substance-K receptor","protein":"Substance-K receptor"},{"gene":"ADRA2B","source":"DrugCentral","target":"Alpha-2B adrenergic receptor","protein":"Alpha-2B adrenergic receptor"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"GENTIAN VIOLET acts as a selective antagonist at the Muscarinic acetylcholine receptor M4, which is a subtype of the muscarinic acetylcholine receptor family. This receptor is involved in various physiological processes, including the regulation of the autonomic nervous system and the modulation of immune responses."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4138","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=GENTIAN%20VIOLET","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GENTIAN VIOLET","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T13:47:43.178841","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:23:18.276287+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"alfentanil","drugSlug":"alfentanil","fdaApproval":"1986-12-29","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"alvimopan","drugSlug":"alvimopan","fdaApproval":"2008-05-20","patentExpiry":"Feb 12, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"anileridine","drugSlug":"anileridine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-target"},{"drugName":"buprenorphine","drugSlug":"buprenorphine","fdaApproval":"1981-12-29","patentExpiry":"Sep 5, 2031","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"butorphanol","drugSlug":"butorphanol","fdaApproval":"1978-08-22","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"cannabidiol","drugSlug":"cannabidiol","fdaApproval":"2018-06-25","patentExpiry":"Oct 13, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"cefapirin","drugSlug":"cefapirin","fdaApproval":"1974-03-12","relationship":"same-target"},{"drugName":"chlorpromazine","drugSlug":"chlorpromazine","fdaApproval":"1957-09-18","patentStatus":"Unknown","relationship":"same-target"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"gentian violet","indications":{"approved":[{"name":"Candidal vulvovaginitis","source":"DrugCentral","snomedId":72605008,"regulator":"FDA","eligibility":"No eligibility criteria provided"}],"offLabel":[{"name":"Candidiasis of skin","source":"DrugCentral","drugName":"GENTIAN VIOLET"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"alfentanil","brandName":"alfentanil","genericName":"alfentanil","approvalYear":"1986","relationship":"same-target"},{"drugId":"alvimopan","brandName":"alvimopan","genericName":"alvimopan","approvalYear":"2008","relationship":"same-target"},{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-target"},{"drugId":"anileridine","brandName":"anileridine","genericName":"anileridine","approvalYear":"","relationship":"same-target"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-target"},{"drugId":"buprenorphine","brandName":"buprenorphine","genericName":"buprenorphine","approvalYear":"1981","relationship":"same-target"},{"drugId":"butorphanol","brandName":"butorphanol","genericName":"butorphanol","approvalYear":"1978","relationship":"same-target"},{"drugId":"cannabidiol","brandName":"cannabidiol","genericName":"cannabidiol","approvalYear":"2018","relationship":"same-target"},{"drugId":"cefapirin","brandName":"cefapirin","genericName":"cefapirin","approvalYear":"1974","relationship":"same-target"},{"drugId":"chlorpromazine","brandName":"chlorpromazine","genericName":"chlorpromazine","approvalYear":"1957","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07482553","phase":"","title":"Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":["Urinary Tract Infections (UTIs)","Catheter-Associated Urinary Tract Infections (CAUTIs)","Biofilm Formation by Uropathogenic Escherichia Coli (UPEC)"],"enrollment":60,"completionDate":"2027-06"},{"nctId":"NCT04354012","phase":"PHASE2","title":"Hidradenitis Suppurativa Wound Care","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-02-04","conditions":["Hidradenitis Suppurativa (HS)"],"enrollment":5,"completionDate":"2024-08-28"},{"nctId":"NCT04388163","phase":"PHASE2","title":"Gentian Violet Treatment for Hidradenitis Suppurativa","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2025-08","conditions":["Hidradenitis Suppurativa"],"enrollment":0,"completionDate":"2026-12"},{"nctId":"NCT03748667","phase":"","title":"Accuracy for Predicting Deep Submucosal Invasion","status":"COMPLETED","sponsor":"Althaia Xarxa Assistencial Universitària de Manresa","startDate":"2018-12-01","conditions":["Colorectal Cancer","Colorectal Polyp"],"enrollment":426,"completionDate":"2022-10-30"},{"nctId":"NCT04705714","phase":"PHASE1","title":"Antibacterial and Anti-biofilm Activity of Frankincense Extract Against Porphyromonas Gingivalis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-01-15","conditions":["Periodontal Diseases"],"enrollment":30,"completionDate":"2021-03-01"},{"nctId":"NCT04657757","phase":"NA","title":"Investigation of Bacterial Adhesion and Bactericide Effect ex Vivo on Different Implant Restoration Materials","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-03-14","conditions":["Dental Diseases"],"enrollment":16,"completionDate":"2020-03-31"},{"nctId":"NCT01427738","phase":"PHASE3","title":"Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2011-06","conditions":["HIV-1 Infection"],"enrollment":221,"completionDate":"2014-01"},{"nctId":"NCT00128323","phase":"PHASE3","title":"A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis","status":"COMPLETED","sponsor":"Kamuzu University of Health Sciences","startDate":"2002-11","conditions":["Candidiasis, Oral"],"enrollment":558,"completionDate":"2005-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Liquid, Solution, Swab, Tincture","formulations":[{"form":"LIQUID","route":"TOPICAL","productName":"El Valle Gentian Violet"},{"form":"LIQUID","route":"TOPICAL","productName":"GNP Gentian Violet 1%"},{"form":"LIQUID","route":"TOPICAL","productName":"Gentian Violet"},{"form":"LIQUID","route":"TOPICAL","productName":"Gentian Violet 1%"},{"form":"LIQUID","route":"TOPICAL","productName":"Gentian Violet Topical Solution"},{"form":"LIQUID","route":"TOPICAL","productName":"Gentian VioletAnti-Infective"},{"form":"LIQUID","route":"TOPICAL","productName":"Humco Gentian Violet 1%"},{"form":"LIQUID","route":"TOPICAL","productName":"Humco Gentian Violet 2%"},{"form":"SOLUTION","route":"TOPICAL","productName":"Gentian Violet 2%"},{"form":"SOLUTION","route":"TOPICAL","productName":"Perineze Triple Dye"},{"form":"SWAB","route":"TOPICAL","productName":"Kerr 100 Triple Dye Dispos-A"},{"form":"TINCTURE","route":"TOPICAL","productName":"DE LA CRUZ GENTIAN VIOLET"}]},"_patentsChecked":true,"crossReferences":{"NUI":"N0000147160","MMSL":"4780","NDDF":"002617","UNII":"J4Z741D6O5","VUID":"4018858","CHEBI":"CHEBI:41688","VANDF":"4018858","INN_ID":"113","RXNORM":"4778","UMLSCUI":"C0017440","chemblId":"CHEMBL64894","ChEMBL_ID":"CHEMBL64894","DRUGBANK_ID":"DB00406","PDB_CHEM_ID":"CVI","PUBCHEM_CID":"11057","SNOMEDCT_US":"387239001","MESH_DESCRIPTOR_UI":"D005840"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":739,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar","pmid":"41772988","title":"Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa.","journal":"Expert review of clinical pharmacology"},{"date":"2026 Feb 21","pmid":"41764862","title":"Integrative Ayurveda management of a chronic unilateral diabetic plantar lesion: A case report.","journal":"Explore (New York, N.Y.)"},{"date":"2026 Feb 23","pmid":"41725525","title":"An optical fiber crystal violet sensor using a porous ITO membrane coated on an optical fiber surface with UV photon-enhanced sensitivity.","journal":"The Analyst"},{"date":"2026 Feb 1","pmid":"41642131","title":"Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy.","journal":"Journal of drugs in dermatology : JDD"},{"date":"2026 Jan 9","pmid":"41510595","title":"Evaluating Gentian Violet as a Low-Cost Alternative for Sentinel Lymph Node Biopsy in Breast Cancer: A Single-Center Retrospective Study.","journal":"Asia-Pacific journal of clinical oncology"}],"companionDiagnostics":[],"genericManufacturers":2,"_genericFilersChecked":true,"genericManufacturerList":["Key Pharms","Savage Labs"],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1982","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:23:18.276287+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}